Clinical trials in Mistelbach

Groundbreaking studies focusing on stroke prevention and management of atrial fibrillation. Research evaluates innovative treatments comparing asundexian to established medications for reducing stroke risk in patients with irregular heartbeat.

• Stroke Prevention
• Atrial Fibrillation Management
• Systemic Embolism Prevention

Trials aim to assess both effectiveness and safety profiles of new therapeutic approaches.

Advanced research in breast cancer treatment, specifically focusing on hormone receptor-positive/HER2-negative early breast cancer. Studies evaluate the effectiveness of combining palbociclib with standard endocrine therapy.

• Early Breast Cancer Treatment
• Endocrine Therapy Enhancement
• Disease-Free Survival Assessment

Research aims to improve treatment outcomes through innovative combination therapies.

Innovative studies examining treatments for acute ischemic stroke and high-risk transient ischemic attacks. Research evaluates the efficacy of milvexian in reducing stroke risk compared to placebo.

• Acute Stroke Treatment
• Ischemic Attack Prevention
• Neurological Recovery

Focus on developing more effective interventions for stroke prevention and management.